Abstract
Background Patients with nervous system and musculoskeletal diseases display gait disturbance that is a leading cause of falls. Identification of disease-specific movement hallmarks is therefore an essential first step in preventing falls. Since turning, a common daily activity, is a unique movement that requires inter-limb spatial coordination, turning may be a suitable observational target for the identification of disease-specific movement disorder. However, to date, few comprehensive systematic review regarding disease-specific alterations in turning movement is available.
Research question This systematic review with meta-analysis summarized the level of knowledge regarding movement disorders during turning in patients with nervous system and musculoskeletal diseases.
Methods A systematic review was conducted of papers throughout 2021 in accordance with PRISMA guideline. Including criteria were (1) were published in a peer-reviewed journal, (2) were written in English, (3) included adult patients who were diagnosed with musculoskeletal or nervous system diseases, (4) had a control group of age-matched healthy adults, and (5) outcomes included turning parameters.
Results Meta-analysis revealed a significantly larger step number, longer turn duration, and shorter step length in patients with Parkinson’s disease (PD) than in controls during the 180° turn, suggesting that these biomechanical alterations may be, at least in part, movement disorders associated with PD. Notably, this review identified methodological heterogeneity for turning movement assessments, which limited the identification of disease-specific movement disorders.
Significance This work serves as a call to action for the establishment of a standard assessment protocol towards the identification of disease-specific turning movement disorders and effective disease screening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
JSPS KAKENHI Grant Number JP20K13807
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We used only data that were openly available to the public before the initiation of the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
ttakeda{at}jmdc.co.jp
ant.fb40{at}gmail.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
